+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Azelnidipine Market by Dosage Form, Distribution Channel, Dosage Strength, Treatment, End User - Global Forecast to 2030- Product Image
Azelnidipine Market by Dosage Form, Distribution Channel, Dosage Strength, Treatment, End User - Global Forecast to 2030- Product Image
Sale

Azelnidipine Market by Dosage Form, Distribution Channel, Dosage Strength, Treatment, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082433
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Azelnidipine market is advancing amid ongoing innovation in antihypertensive therapy, presenting new opportunities and challenges for industry leaders focused on cardiovascular care. As regulatory requirements shift and technology integration increases, strategic approaches must evolve to capture value across the supply chain.

Market Snapshot: Azelnidipine Market at a Glance

The Azelnidipine market grew from USD 535.56 million in 2024 to USD 564.80 million in 2025. It is projected to expand further at a CAGR of 5.30%, reaching USD 730.50 million by 2030. This growth is supported by Azelnidipine’s positioning as a dihydropyridine calcium channel blocker that delivers sustained blood pressure control and a favorable safety profile. Rising demand is underpinned by evolving treatment protocols and a broadening patient base, resulting in robust adoption among clinicians, payers, and manufacturers.

Scope & Segmentation

This analysis offers a comprehensive review of the Azelnidipine market, capturing granular detail on market structure, emerging technologies, and critical patient and regional profiles. The segmentation highlights specific product and distribution characteristics impacting market performance.

  • Dosage Forms: Capsules (hard and soft gel), oral suspension, extended release tablets, immediate release tablets.
  • Distribution Channels: Hospital pharmacies, online pharmacies (manufacturer direct sales, third-party platforms), retail pharmacies (chain and independent retailers).
  • Dosage Strengths: 16 mg and 8 mg formulations tailored to varying therapeutic requirements.
  • Treatment Types: Combination therapies (with ACE inhibitors, ARBs, and diuretics) and individual monotherapy options.
  • End User Groups: Clinics (general and specialist), home care settings, hospitals (primary, secondary, tertiary).
  • Regional Coverage: Americas (United States—by major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Company Analysis: Major contributors include Daiichi Sankyo Co., Ltd., Nichi-Iko Pharmaceutical Co., Ltd., Kaken Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Sawai Pharmaceutical Co., Ltd., and Dr. Reddy's Laboratories Ltd.

Key Takeaways for Senior Decision-Makers

  • Azelnidipine’s distinct pharmacokinetic profile supports its growth amid evolving patient-centric cardiovascular treatment paradigms.
  • The adoption of digital health tools and telemedicine is transforming adherence monitoring and driving operational efficiencies in distribution and care delivery.
  • Strategic partnerships between major pharmaceutical and biotechnology firms are accelerating innovation, especially in co-formulated fixed-dose combinations.
  • Stakeholder alignment is increasingly shaped by value-based agreements and outcome-linked reimbursement strategies, which offset pressure from regulatory pricing and procurement challenges.
  • Manufacturers are responding to variable regional demand and regulatory diversity by tailoring supply, channel strategies, and pricing models to local market nuances.
  • Regional shifts toward direct-to-consumer and online pharmacy platforms are strengthening patient engagement and expanding market access, especially in areas with robust digital infrastructure.

Tariff Impact: Responding to 2025 US Trade Dynamics

The elevated US import tariffs on critical active pharmaceutical ingredients in 2025 created significant challenges, including heightened procurement costs and supply chain adjustments. Leading companies diversified sourcing and established domestic partnerships to mitigate risks. Inventory and demand forecasting strategies strengthened supply continuity, while value-based contracts with payers offered a path to absorb incremental costs.

Methodology & Data Sources

The report is grounded in in-depth interviews with key opinion leaders such as cardiologists and procurement specialists. Supplemented by secondary data from peer-reviewed literature, regulatory documentation, and company reports, the methodology utilizes data triangulation and scenario modeling to validate segmentation and competitive positioning.

Why This Report Matters

  • Senior leaders gain actionable insights into evolving stakeholder priorities, supporting high-impact investment and R&D decisions in the Azelnidipine sector.
  • Granular segmentation and regional analysis enable agile responses to changing demand dynamics and regulatory variations, optimizing both product launches and market expansion strategies.
  • Clear competitive mapping and supply chain intelligence help inform pricing, maneuvering around tariff and procurement disruptions.

Conclusion

The Azelnidipine market presents tangible opportunities for growth through innovation, digital integration, and resilient supply chain strategies. An informed, agile approach—grounded in robust segmentation and regional intelligence—enables stakeholders to unlock lasting value.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Azelnidipine Market, by Dosage Form
8.1. Introduction
8.2. Capsules
8.2.1. Hard Capsule
8.2.2. Soft Gel Capsule
8.3. Oral Suspension
8.4. Tablets
8.4.1. Extended Release
8.4.2. Immediate Release
9. Azelnidipine Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.3.1. Manufacturer Direct Sales
9.3.2. Third Party Platforms
9.4. Retail Pharmacy
9.4.1. Chain Retail
9.4.2. Independent Retail
10. Azelnidipine Market, by Dosage Strength
10.1. Introduction
10.2. 16 Mg
10.3. 8 Mg
11. Azelnidipine Market, by Treatment
11.1. Introduction
11.2. Combination Therapy
11.2.1. Ace Inhibitor Combination
11.2.2. Arb Combination
11.2.3. Diuretic Combination
11.3. Monotherapy
12. Azelnidipine Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. General Clinics
12.2.2. Specialist Clinics
12.3. Home Care
12.4. Hospitals
12.4.1. Primary Hospitals
12.4.2. Secondary Hospitals
12.4.3. Tertiary Hospitals
13. Americas Azelnidipine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Azelnidipine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Azelnidipine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Daiichi Sankyo Co., Ltd.
16.3.2. Nichi-Iko Pharmaceutical Co., Ltd.
16.3.3. Kaken Pharmaceutical Co., Ltd.
16.3.4. Sun Pharmaceutical Industries Ltd.
16.3.5. Sawai Pharmaceutical Co., Ltd.
16.3.6. Dr. Reddy's Laboratories Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AZELNIDIPINE MARKET MULTI-CURRENCY
FIGURE 2. AZELNIDIPINE MARKET MULTI-LANGUAGE
FIGURE 3. AZELNIDIPINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AZELNIDIPINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AZELNIDIPINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AZELNIDIPINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AZELNIDIPINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AZELNIDIPINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AZELNIDIPINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AZELNIDIPINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AZELNIDIPINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AZELNIDIPINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AZELNIDIPINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AZELNIDIPINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AZELNIDIPINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AZELNIDIPINE MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AZELNIDIPINE MARKET SIZE, BY SOFT GEL CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AZELNIDIPINE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AZELNIDIPINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AZELNIDIPINE MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AZELNIDIPINE MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AZELNIDIPINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AZELNIDIPINE MARKET SIZE, BY MANUFACTURER DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AZELNIDIPINE MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AZELNIDIPINE MARKET SIZE, BY CHAIN RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AZELNIDIPINE MARKET SIZE, BY INDEPENDENT RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AZELNIDIPINE MARKET SIZE, BY 16 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AZELNIDIPINE MARKET SIZE, BY 8 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AZELNIDIPINE MARKET SIZE, BY ACE INHIBITOR COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AZELNIDIPINE MARKET SIZE, BY ARB COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AZELNIDIPINE MARKET SIZE, BY DIURETIC COMBINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AZELNIDIPINE MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AZELNIDIPINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AZELNIDIPINE MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AZELNIDIPINE MARKET SIZE, BY SPECIALIST CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AZELNIDIPINE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AZELNIDIPINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AZELNIDIPINE MARKET SIZE, BY PRIMARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AZELNIDIPINE MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AZELNIDIPINE MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES AZELNIDIPINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. CANADA AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 74. CANADA AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 75. CANADA AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 76. CANADA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. CANADA AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 78. CANADA AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 79. CANADA AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 80. CANADA AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. CANADA AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 82. CANADA AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. CANADA AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 84. CANADA AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 86. MEXICO AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 87. MEXICO AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. MEXICO AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 90. MEXICO AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 91. MEXICO AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 92. MEXICO AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. MEXICO AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 94. MEXICO AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. MEXICO AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. GERMANY AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 147. GERMANY AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 148. GERMANY AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 149. GERMANY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. GERMANY AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 151. GERMANY AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 152. GERMANY AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 153. GERMANY AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. GERMANY AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 155. GERMANY AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. GERMANY AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 158. FRANCE AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 159. FRANCE AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 160. FRANCE AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 161. FRANCE AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. FRANCE AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 163. FRANCE AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 164. FRANCE AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 165. FRANCE AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. FRANCE AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 167. FRANCE AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. FRANCE AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. ITALY AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 183. ITALY AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 184. ITALY AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 185. ITALY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. ITALY AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 187. ITALY AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 188. ITALY AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 189. ITALY AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 190. ITALY AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 191. ITALY AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. ITALY AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 193. ITALY AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 194. SPAIN AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 195. SPAIN AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 196. SPAIN AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 197. SPAIN AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. SPAIN AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 199. SPAIN AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 200. SPAIN AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 201. SPAIN AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 202. SPAIN AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 203. SPAIN AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SPAIN AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. DENMARK AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 243. DENMARK AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 244. DENMARK AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 245. DENMARK AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. DENMARK AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 247. DENMARK AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 248. DENMARK AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 249. DENMARK AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 250. DENMARK AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 251. DENMARK AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. DENMARK AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 253. DENMARK AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 266. QATAR AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 267. QATAR AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 268. QATAR AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 269. QATAR AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. QATAR AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 271. QATAR AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 272. QATAR AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 273. QATAR AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 274. QATAR AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 275. QATAR AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. QATAR AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 277. QATAR AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 278. FINLAND AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 279. FINLAND AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 280. FINLAND AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 281. FINLAND AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. FINLAND AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 283. FINLAND AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 284. FINLAND AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 285. FINLAND AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 286. FINLAND AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 287. FINLAND AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. FINLAND AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 289. FINLAND AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 314. EGYPT AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 315. EGYPT AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 316. EGYPT AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 317. EGYPT AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. EGYPT AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 319. EGYPT AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 320. EGYPT AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 321. EGYPT AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 322. EGYPT AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 323. EGYPT AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. EGYPT AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 325. EGYPT AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 326. TURKEY AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 327. TURKEY AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 328. TURKEY AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 329. TURKEY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. TURKEY AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 331. TURKEY AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 332. TURKEY AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 333. TURKEY AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 334. TURKEY AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 335. TURKEY AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. TURKEY AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 337. TURKEY AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 338. ISRAEL AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 339. ISRAEL AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 340. ISRAEL AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 341. ISRAEL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. ISRAEL AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 343. ISRAEL AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 344. ISRAEL AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 345. ISRAEL AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 346. ISRAEL AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 347. ISRAEL AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 348. ISRAEL AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 349. ISRAEL AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 350. NORWAY AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 351. NORWAY AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 352. NORWAY AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 353. NORWAY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 354. NORWAY AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 355. NORWAY AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 356. NORWAY AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 357. NORWAY AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 358. NORWAY AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 359. NORWAY AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 360. NORWAY AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 361. NORWAY AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 362. POLAND AZELNIDIPINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 363. POLAND AZELNIDIPINE MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 364. POLAND AZELNIDIPINE MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 365. POLAND AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 366. POLAND AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 367. POLAND AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 368. POLAND AZELNIDIPINE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 369. POLAND AZELNIDIPINE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 370. POLAND AZELNIDIPINE MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 371. POLAND AZELNIDIPINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 372. POLAND AZELNIDIPINE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 373. POLAND AZELNIDIPINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Azelnidipine market report include:
  • Daiichi Sankyo Co., Ltd.
  • Nichi-Iko Pharmaceutical Co., Ltd.
  • Kaken Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sawai Pharmaceutical Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 564.8 Million
Forecasted Market Value ( USD ) by 2030 $ 730.5 Million
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Azelnidipine (CAS 123524-52-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Azelnidipine (CAS 123524-52-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Antihypertensive Drugs Market by Therapeutic Class, Therapy Type, Administration Route, Dosage Form, Distribution Channel, End Users - Global Forecast to 2030 - Product Image

Antihypertensive Drugs Market by Therapeutic Class, Therapy Type, Administration Route, Dosage Form, Distribution Channel, End Users - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Heart Transplantation Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Immunosuppressants, Anti-infectives, Analgesics), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Heart Transplantation Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Immunosuppressants, Anti-infectives, Analgesics), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Andexanet Alfa, Idarucizumab, Phytonadione (Vitamin K)), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Andexanet Alfa, Idarucizumab, Phytonadione (Vitamin K)), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Azelnidipine Market

Azelnidipine is a calcium channel blocker used to treat hypertension and angina pectoris. It is a dihydropyridine derivative and is classified as a third-generation calcium channel blocker. It is used to reduce blood pressure and improve blood flow to the heart. It works by blocking the entry of calcium into the cells of the heart and blood vessels, which helps to relax the blood vessels and reduce blood pressure. Azelnidipine is available in both oral and intravenous formulations. It is marketed under various brand names, including Azelnidipine, Azelnidipine-H, Azelnidipine-L, and Azelnidipine-XL. It is available in various strengths and formulations, including tablets, capsules, and oral solutions. Azelnidipine is used in combination with other drugs to treat hypertension and angina pectoris. It is also used to reduce the risk of stroke and heart attack in patients with coronary artery disease. The azelnidipine market is highly competitive, with several major players operating in the space. Some of the key players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.